@PrimeTrading_ If I was in your chat room and accidentally posted a bullish message in your short thread would you kick me out! 🤣
English
Sacal
2.2K posts
Sacal
@CalvaneseSam
Full Time Trader - Consistently Profitable Since 2017
Katılım Nisan 2022
66 Takip Edilen286 Takipçiler
$AMZN is fading hard after tapping the declining 21dma-structure. Earnings after close.
English
Sacal retweetledi
Having focus on the structure instead on Ind. bars & 1-3 days moves will save you a lot of struggle.
English
@insane_analyst @SFWTrades These stocks are still so overpriced. But hey if you didn't trade in 1999-2001 only 1 way to learn I guess. I hope you have better fortune though.
English
Allright time to take a break.
You may think I am an idiot (I am) but at least I'm the most transparent idiot.
English
I had to read these triple times to make sure I wasn’t day dreaming.
WOW just wow. Burry’s biggest nightmare. He just published a letter of private credit risk financing, and now we have the central bank of AI backing. 🤯
Nicholas Mugalli@RealNickMugalli
🇺🇸🇯🇵 US government controlled power, Japanese funded natural gas on federal land, and a $250B credit wrapper backed by $NVDA to lower SoftBank’s cost of capital $NVDA is trading pure hardware vendor status for sovereign backed credit risk just to keep the AI buildout on schedule
English
To arrange in and out of PEM sampling, send me a DM, email support@amaticahealth.com, or order two RNA tests at amaticahealth.com and complete the questionnaires for each sample accordingly.
English
The second sample is typically collected when PEM has occurred naturally.
We do not ask people to trigger PEM specifically for the blood draw, as this could cause unnecessary harm.
English
@JackHadfield14 Is the lab that is running these tests CLIA and CAP accredited?
English
For those interested, we offer in and out of post-exertional malaise sampling through the Amatica RNA test.
This involves collecting one RNA sample at baseline and another during PEM. Both samples are sequenced separately, and you receive a separate RNA report for each sample.
English
@internetuserf12 I’m in the trial, but don’t have diabetes and it’s done nothing.
English
Hot take: Semaglutide currently has the most direct clinical evidence in Long Covid. Mechanistically, GLP-1RAs influence metabolism, mitochondrial function, endothelial health, neuroimmune signaling, and inflammation. Tirzepatide may have even greater theoretical anti-inflammatory potential through combined GLP-1/GIP signaling and is currently being studied in Long Covid. Triple agonists are promising for severe metabolic disease, but in energy-limited phenotypes, additional metabolic stimulation could theoretically increase mitochondrial stress - a mechanistic synthesis, not an established finding, don't quote me. 🤗
English
@RealJimChanos Jim, haven’t you already downsized to a family office because of short losses from TSLA? Why not move on, enjoy life.
English
(4) And with FSD currently less than a $2B ARR business (1.5M paying subscribers at $100/month), $TSLA just told us how small two of the biggest TAM narratives (FSD and Robotaxis) they have really are. That’s likely why Musk is now pivoting to chip production (Terafab).
English
The disclosure by $TSLA on their 2Q conference call that they had completed 380,000 unsupervised Robotaxi miles over the past year was a stunning admission, and the likely reason for the stock’s big decline over the past two days.
English
@PutrinoLab @lenadunham @meghanor A money grab - but there’s probably millions of people with severe mental illness that turns into chronic pain. That is why we need biomarkers.
English
Ok. No one get mad, but:
@lenadunham’s Famesick
🤝
@meghanor’s The Invisible Kingdom
Medicine still has a lot of work to do to stop failing people with complex chronic illness.
English
@BearBanker @lisaabramowicz1 Gotta love this guy thinks he is smarter than CEO’s running trillion $ market caps and billions in net worth
English
As an old credit analyst I see AI has become a mass psychosis, with CEO's and CFO's mismanaging their companies and their cash. No one seems to realize that AI is ultimately an inherently self cannibalizing technology. As it grows more and more efficient, each new unit of data output will cost less and be easier and faster to produce. Therefore, much, if not most of the current AI investment mania will ultimately be wasted, with few returns for anybody. Caveat Emptor.
English
Alphabet highlights how much the hyperscaler landscape has changed. These companies used to be cash-producing machines. Now, Google's parent company just posted its first negative free cashflow quarter since at least 2016.
English
THAT kind of market. Even some of the best charts can't hold.
$NAVN
Francesco@FranVezz
@BigWaveChartist Looks amazing. Just wish it wasn't like the only name that looks good along with some software lol!
English
@monkemarkets Maybe it got the needed washout yesterday. Will watch for a long entry now
English
@pwginsburg Nothing to make an issue Peter. Scarcity of money is the best scenario for us and it’s working as Simmaron, Poly Bio and plenty of others are quickly advancing diagnostics and treatments.
English
So, WTF can we do about Long Covid research? There's an election in 3 mo. I asked the Google God, how many voters have LC, and it said ... 13-19.5 million voters. That's a big voting block, about 12% of voters in 2024. It can sway an election. We have to make it an issue. NOW.
English
@internetuserf12 I’m unaware of a single trial in the US or Europe that shows treating the microbiome has large scale positive impacts on Long Covid. Yet the recent results from Simmaron on Rapamycin do and you haven’t mentioned it once.
English
Some of the strongest therapeutic signaling in Long Covid research comes from treating the microbiome, specifically with SIM01 and similar formulas that increase bifido and SCFAs.
a.co/d/08MGkxfU
English
@AdamMancini4 You ever think about starting an alert service for your trades or a chat room?
English
Note: Reclaims of 7522 are also actionable but 7533 resistance is still just above.
English
After days of summer chop #ES_F *finally* got some some small volatility expansion overnight that may produce trades today if it sticks.
Plan today: 7533 is key today. Bulls must reclaim to see 7540, 7546, 7555, 7575. 7575 must backtest. 7482, 7467 (watch traps)=next supports
Adam Mancini@AdamMancini4
There remains nothing to do now in #ES_F and we've got a 2 target run today. 95% of summer trading is riding a runner. 7594 reclaims was low quality trigger. Target slate = 7604 (hit), 7611 (hit), 7621, 7639 still outstanding. 7570-75=support (watch traps). 7555, 7533 below
English
$CRWV 🚨 BREAKING NEWS 🚨
CoreWeave's next move could surprise a lot of investors.
First half 2026 EPS Estimate 👉"98 cents" ❌
Second half 2026 EPS estimate 👉"120 cents" 🚀
English
@CallahanCakfx I’ll help you out, first look at market cap. Onds is already overvalued at $6 it’s going to $4
English
I’ll only say this once: By 2026, you could become a millionaire.
$ASTS is a $500 stock trading at $55
$HIMS is a $100 stock trading at $33
$ONDS is a $20 stock trading at $6
$OSCR is a $50 stock trading at $28
$ABCL is a $20 stock trading at $6.16
$SOFI is a $50 stock trading at $17
$KRKNF is a $20 stock trading at $4.18
A price divergence this massive won’t last long. Like, follow, and save this post — come back in six months. By then, most of these stocks will be moving toward the target prices above.
English